DRAP Requires 2-D Barcodes and Serialization on Imported Finished Pharmaceutical Products
DRAP has issued a notification on mandatory compliance with 2-D barcode and serialization requirements for imported finished pharmaceutical products. A corrigendum to the notification was released on the same day, 7 September 2026.
The requirements form part of DRAP's move towards a track-and-trace system for medicines. In a related notice, DRAP also announced the closure of the deadline for data validation on its eApp software for integration with the track-and-trace system. The notification and corrigendum are available to download from DRAP.
Key points
- Applies to imported finished pharmaceutical products.
- Products must comply with 2-D barcode and serialization requirements.
- A corrigendum was issued alongside the notification; read both together.
- DRAP has separately closed the eApp data-validation deadline for track-and-trace integration.
What it means for you
Importers and distributors should review the notification and corrigendum for compliance dates. For pharmacists, serialized barcodes should in time make it easier to verify genuine stock and trace recalled batches.
Mandatory Compliance with 2-D Barcode and Serialization Requirements for Imported Finished Pharmaceutical Products
Summarised automatically from the official announcement. For educational purposes only — check the original source before making clinical decisions.